LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $552,402 | -16.9% | 9,219 | 0.0% | 0.18% | -26.6% |
| Q2 2023 | $664,690 | -2.0% | 9,219 | 0.0% | 0.24% | +0.8% |
| Q1 2023 | $678,150 | +197.4% | 9,219 | +248.4% | 0.24% | +36.6% |
| Q3 2022 | $228,000 | +13.4% | 2,646 | +100.3% | 0.18% | +182.3% |
| Q1 2021 | $201,000 | -87.5% | 1,321 | -92.2% | 0.06% | -91.9% |
| Q3 2020 | $1,610,000 | -0.7% | 16,887 | +16.4% | 0.77% | -0.1% |
| Q2 2020 | $1,622,000 | +109.3% | 14,505 | +36.1% | 0.77% | +43.8% |
| Q1 2020 | $775,000 | -50.4% | 10,661 | -28.8% | 0.54% | +34.7% |
| Q4 2019 | $1,561,000 | – | 14,964 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |